OPINION OF THE COURT
HASTIE, Chief Judge.
Kaybel, Inc., a wholesale drug distributor, its president and its secretary-treasurer were charged with introducing a "new drug," Enovid 5 mg., into interstate commerce in violation of 21 U. S.C. § 355(a), in that no approved new drug application was effective with respect to that drug. After trial before a jury, and after the court had denied the defendants' motion...
Let's get started
Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.
- Updated daily.
- Uncompromising quality.
- Complete, Accurate, Current.